John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes

    BMC Medicine Date published:

  • Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials

    Stroke Date published:

  • The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

    Diabetologia Date published:

  • Changes in plasma lipids predict pravastatin efficacy in secondary prevention

    JCI Insight Date published:

  • Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage

    Journal of Hypertension Date published:

  • Who will benefit more from low-dose alteplase in acute ischemic stroke?

    International Journal of Stroke Date published:

  • Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage

    Stroke Date published:

  • Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes

    Clinical Journal of the American Society of Nephrology Date published:

  • 409-P: Cardiac Biomarkers and Incident Peripheral Arterial Disease (PAD) in Patients with Type 2 Diabetes in the ADVANCE Trial

    Diabetes Date published:

  • 251-OR: Relationship of Short-Term HbA1c Change with Vascular Events, Severe Hypoglycaemia, and Mortality

    Diabetes Date published:

  • Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

    Hypertension Date published:

  • Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)

    BMJ Open Date published:

  • Infratentorial Intracerebral Hemorrhage

    Stroke Date published:

  • Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

    International Journal of Stroke Date published:

  • C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register

    Diabetes Research and Clinical Practice Date published: